Entera Bio LTD. (ENTX) — 8-K Filings

8-K Filings (9)

• Entera Bio Ltd. Files 8-K on Financials and Warrants — Aug 8, 2025 Risk: medium
  Entera Bio Ltd. filed an 8-K on August 8, 2025, reporting on its financial condition and results of operations. The filing also includes Regulation FD disclosur
• Entera Bio Ltd. Files 8-K on Warrants and Operations — Jul 28, 2025 Risk: medium
  Entera Bio Ltd. filed an 8-K on July 28, 2025, reporting on various events. The filing includes information about warrants exercisable for Ordinary Shares at an
• Entera Bio Ltd. Files 8-K on Shareholder Vote Matters — Jul 18, 2025 Risk: medium
  Entera Bio Ltd. filed an 8-K on July 18, 2025, reporting a submission of matters to a vote of security holders on July 16, 2025. The company is involved in biol
• Entera Bio Ltd. Discloses Warrant Agreement and Equity Sales — Mar 17, 2025 Risk: medium
  Entera Bio Ltd. announced on March 16, 2025, the entry into a material definitive agreement related to warrants. These warrants are exercisable for half of an O
• Entera Bio Ltd. Files 8-K on Warrants — Jan 10, 2025 Risk: low
  Entera Bio Ltd. filed an 8-K on January 10, 2025, reporting on financial statements and exhibits. The filing details warrants exercisable for half an Ordinary S
• Entera Bio Ltd. Raises $10M via Share and Warrant Offering — Aug 2, 2024 Risk: medium
  Entera Bio Ltd. announced on July 31, 2024, that it has entered into a securities purchase agreement to sell approximately $10.0 million of its ordinary shares
• Entera Bio Ltd. Warrants Listed on NASDAQ — Mar 4, 2024 Risk: medium
  Entera Bio Ltd. announced on March 4, 2024, that its warrants, exercisable for half an Ordinary Share at $5.85, are listed on NASDAQ under the ticker ENTXW. Thi
• Entera Bio Details Warrants: $5.85 Exercise Price Per Share — Feb 2, 2024
  Entera Bio Ltd. filed an 8-K on February 2, 2024, disclosing information about its Warrants, which are exercisable for half of an Ordinary Share at an exercise
• Entera Bio Warrants (ENTXW) Exercisable at $5.85/Share — Jan 3, 2024
  On January 3, 2024, Entera Bio Ltd. filed an 8-K to report that its warrants, trading under the symbol ENTXW on NASDAQ, are each exercisable for half of an Ordi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX